Marvell Technology Files Form 10-K For Year Ended January 27, 2007 ...
RTT News - Williamsville,NY,USA
Welcome NICE Recommendation For Use Of TYSABRI In Highly Active Relapsing Remitting Multiple Sclerosis [BIIB] 7/2/2007 7:23:27 PM Monday, Biogen Idec (BIIB) ...
See all stories on this topic

MS Society Welcomes Tysabri 'Yes'
ITNews - Roma,Italy
NICE had been poised to reject Tysabri - a drug that stops immune cells leaving the blood stream and entering areas of inflammation - on cost and efficacy ...
See all stories on this topic

TYSABRI(r) Recommended by NICE for Use in Highly Active Relapsing ...
Business Wire (press release) - San Francisco,CA,USA
TYSABRI is the first treatment for multiple sclerosis to be recommended for use by NICE. "This decision offers people with highly active relapsing remitting ...
See all stories on this topic

News in Brief
Times Online - UK
The National Institute for Health and Clinical Excellence had earlier ruled out widespread use of Tysabri on the ground of cost. ...
See all stories on this topic

Market Report -- In Play (BIIB)
MSN Money - USA
Biogen Idec announced TYSABRI recommended by NICE for use in highly active relapsing remitting multiple sclerosis in the final appraisal determination Co ...
See all stories on this topic